147 related articles for article (PubMed ID: 33928551)
1. Identification of Human Antigen-Specific CD4+ Cells with Peptide-MHC Multimer Technologies.
Chow IT; Kwok WW
Methods Mol Biol; 2021; 2285():153-163. PubMed ID: 33928551
[TBL] [Abstract][Full Text] [Related]
2. Identification of Human Antigen-Specific CD4
Kong YY; Kwok WW
Methods Mol Biol; 2019; 1988():375-386. PubMed ID: 31147953
[TBL] [Abstract][Full Text] [Related]
3. Optimized combinatorial pMHC class II multimer labeling for precision immune monitoring of tumor-specific CD4 T cells in patients.
Rockinger GA; Guillaume P; Cachot A; Saillard M; Speiser DE; Coukos G; Harari A; Romero PJ; Schmidt J; Jandus C
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32448802
[TBL] [Abstract][Full Text] [Related]
4. The Use of pMHCII Tetramer Technology for the Identification and Characterization of CD4+ T Cells.
Wambre E
Methods Mol Biol; 2019; 2020():153-164. PubMed ID: 31177498
[TBL] [Abstract][Full Text] [Related]
5. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
[TBL] [Abstract][Full Text] [Related]
6. Detection of EXP1-Specific CD4+ T Cell Responses Directed Against a Broad Range of Epitopes Including Two Promiscuous MHC Class II Binders During Acute
Heide J; Wildner NH; Ackermann C; Wittner M; Marget M; Sette A; Sidney J; Jacobs T; Schulze Zur Wiesch J
Front Immunol; 2019; 10():3037. PubMed ID: 32038611
[No Abstract] [Full Text] [Related]
7. Optimized Protocol for the Detection of Multifunctional Epitope-Specific CD4
Pastore G; Carraro M; Pettini E; Nolfi E; Medaglini D; Ciabattini A
Front Immunol; 2019; 10():2304. PubMed ID: 31649661
[TBL] [Abstract][Full Text] [Related]
8. Use of MHC class II tetramers to investigate CD4+ T cell responses: problems and solutions.
Cecconi V; Moro M; Del Mare S; Dellabona P; Casorati G
Cytometry A; 2008 Nov; 73(11):1010-8. PubMed ID: 18612991
[TBL] [Abstract][Full Text] [Related]
9. Determination of a Predictive Cleavage Motif for Eluted Major Histocompatibility Complex Class II Ligands.
Paul S; Karosiene E; Dhanda SK; Jurtz V; Edwards L; Nielsen M; Sette A; Peters B
Front Immunol; 2018; 9():1795. PubMed ID: 30127785
[TBL] [Abstract][Full Text] [Related]
10. Construction and Screening of an Antigen-Derived Peptide Library Displayed on Yeast Cell Surface for CD4+ T Cell Epitope Identification.
Wen F; Smith MR; Zhao H
Methods Mol Biol; 2019; 2024():213-234. PubMed ID: 31364052
[TBL] [Abstract][Full Text] [Related]
11. Reliable generation and use of MHC class II:gamma2aFc multimers for the identification of antigen-specific CD4(+) T cells.
Arnold PY; Vignali KM; Miller TB; La Gruta NL; Cauley LS; Haynes L; Scott Adams P; Swain SL; Woodland DL; Vignali DA
J Immunol Methods; 2002 Dec; 271(1-2):137-51. PubMed ID: 12445737
[TBL] [Abstract][Full Text] [Related]
12. Direct ex vivo analysis of allergen-specific CD4+ T cells.
Kwok WW; Roti M; Delong JH; Tan V; Wambre E; James EA; Robinson D
J Allergy Clin Immunol; 2010 Jun; 125(6):1407-1409.e1. PubMed ID: 20513526
[No Abstract] [Full Text] [Related]
13. Use of soluble MHC class II/peptide multimers to detect antigen-specific T cells in human disease.
Bill JR; Kotzin BL
Arthritis Res; 2002; 4(4):261-5. PubMed ID: 12106497
[TBL] [Abstract][Full Text] [Related]
14. Multiplex mapping of CD4 T cell epitopes using class II tetramers.
Yang J; James EA; Huston L; Danke NA; Liu AW; Kwok WW
Clin Immunol; 2006 Jul; 120(1):21-32. PubMed ID: 16677863
[TBL] [Abstract][Full Text] [Related]
15. A universal MHCII technology platform to characterize antigen-specific CD4
Vyasamneni R; Kohler V; Karki B; Mahimkar G; Esaulova E; McGee J; Kallin D; Sheen JH; Harjanto D; Kirsch M; Poran A; Dong J; Srinivasan L; Gaynor RB; Bushway ME; Srouji JR
Cell Rep Methods; 2023 Jan; 3(1):100388. PubMed ID: 36814840
[TBL] [Abstract][Full Text] [Related]
16. Identification of MHC class II-restricted tumor antigens recognized by CD4+ T cells.
Wang RF
Methods; 2003 Mar; 29(3):227-35. PubMed ID: 12725788
[TBL] [Abstract][Full Text] [Related]
17. Flow Cytometric Clinical Immunomonitoring Using Peptide-MHC Class II Tetramers: Optimization of Methods and Protocol Development.
Jansen DTSL; Ramnoruth N; Loh KL; Rossjohn J; Reid HH; Nel HJ; Thomas R
Front Immunol; 2018; 9():8. PubMed ID: 29403492
[TBL] [Abstract][Full Text] [Related]
18. Activated human epitope-specific T cells identified by class II tetramers reside within a CD4high, proliferating subset.
Novak EJ; Masewicz SA; Liu AW; Lernmark A; Kwok WW; Nepom GT
Int Immunol; 2001 Jun; 13(6):799-806. PubMed ID: 11369708
[TBL] [Abstract][Full Text] [Related]
19. HLA class II peptide tetramers vs allergen-induced proliferation for identification of allergen-specific CD4 T cells.
Van Hemelen D; Mahler V; Fischer G; Fae I; Reichl-Leb V; Pickl W; Jutel M; Smolinska S; Ebner C; Bohle B; Jahn-Schmid B
Allergy; 2015 Jan; 70(1):49-58. PubMed ID: 25236500
[TBL] [Abstract][Full Text] [Related]
20. Fluorescent target array T helper assay: a multiplex flow cytometry assay to measure antigen-specific CD4+ T cell-mediated B cell help in vivo.
Quah BJ; Wijesundara DK; Ranasinghe C; Parish CR
J Immunol Methods; 2013 Jan; 387(1-2):181-90. PubMed ID: 23123200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
